Cargando…
Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract
BACKGROUND: Malignant melanoma of the female genital tract is relatively uncommon and accounts for 3–7% of all melanoma localizations. This study aimed to identify driver genes in melanoma of the female genital tract with the purpose of enhancing understanding of disease pathogenesis and identifying...
Autores principales: | Cai, Yuan-jun, Ke, Long-feng, Zhang, Wen-wen, Lu, Jian-ping, Chen, Yan-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185938/ https://www.ncbi.nlm.nih.gov/pubmed/34102999 http://dx.doi.org/10.1186/s12885-021-08427-x |
Ejemplares similares
-
A case of synchronous mucinous metaplasia and neoplasia of the female genital tract without an STK11 or KRAS mutation()
por: Nagahama, Kiyotaka, et al.
Publicado: (2013) -
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
por: Indini, Alice, et al.
Publicado: (2019) -
Relevance of BRAF Subcellular Localization and Its Interaction with KRAS and KIT Mutations in Skin Melanoma
por: Beleaua, Marius-Alexandru, et al.
Publicado: (2021) -
Malignant Melanoma of the Female Genital Tract: Experience of an Oncology Center in Pakistan
por: Shakeel, Osama, et al.
Publicado: (2020) -
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
por: Hintzsche, Jennifer D., et al.
Publicado: (2017)